跳至主要内容
临床试验/NCT03993314
NCT03993314终止2 期

Comparing 1% Spinal Chloroprocaine to Low-dose Bupivacaine Using the Epidural Volume Extension Technique for Post-Partum Tubal Ligation

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2019年8月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
15
试验地点
1
主要终点
Number of Patients Who Achieve a Level of Numbness of T6 or Higher

研究概览

简要总结

In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible for enrollment in this study. Outcomes measured will include: ability to achieve an adequate level required for surgery (T6), rate of epidural activation, and duration of the block. The investigators hope to determine the usefulness of each drug using the EVE technique in the setting of PPBTL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Any patient scheduled for a postpartum tubal ligation at the Women and Infants Center will be eligible for the study

排除标准

  • age less than 18 years old
  • allergy to either local anesthetic class (amide or ester)
  • contraindication to spinal anesthesia

研究组 & 干预措施

Bupivacaine

Active Comparator

1 ml 0.5% isobaric bupivacaine (5 mg) + 15 mcg fentanyl intrathecal plus epidural volume extension (EVE)

干预措施: Bupivacaine (Drug)

Chloroprocaine

Experimental

5 ml 1% spinal chloroprocaine (50 mg) intrathecal plus epidural volume extension (EVE)

干预措施: Chloroprocaine (Drug)

结局指标

主要结局

Number of Patients Who Achieve a Level of Numbness of T6 or Higher

时间窗: 10 minutes after spinal injection

Degree of analgesia is determined by the level of the block. Block level may be T1 (highest level of numbness), T2, T3, T4, T5, T6, T7,T8, T9 , T10, T11, T12, L1, L2, L3, or L4 (lowest level or numbness). A level of numbness of T6 or higher is required for an adequate surgical block. Participants are classified as having either an adequate level of numbness (T1, T2, T3, T4, T5, or T6) or an inadequate level (T7,T8, T9 , T10, T11, T12, L1, L2, L3, or L4).

Level of Numbness

时间窗: 10 minutes after spinal injection

The degree to which participants experience analgesia. Degree of analgesia is determined by the level of the block. Block level may be T1 (highest level of numbness), T2, T3, T4, T5, T6, T7,T8, T9 , T10, T11, T12, L1, L2, L3, or L4 (lowest level or numbness). Participants are assigned a numerical score according to level of the block. Numerical scores were assigned so that a higher score indicates better outcome (i.e., greater level of numbness): T1 = 16 points; T2 = 15 points; T3 = 14 points; T4 = 13 points; T5 = 12 points; T6 = 11 points; T7 = 10 points; T8 = 9 points; T9 = 8 points; T10 = 7 points; T11 = 6 points; T12 = 5 points; L1 = 4 points; L2 = 3 points; L3 = 2 points; L4 = 1 point

次要结局

  • Supplemental Intravenous Sedation or General Anesthesia(Day of surgery)
  • Modified Bromage Score at 10 Minutes Post-injection(10 minutes after spinal injection)
  • Time to PACU Discharge(Day of surgery)
  • Modified Bromage Score 60 Minutes After Intrathecal Injection(60 minutes after spinal injection)
  • Epidural Activation(Day of surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark Powell

Principal Investigator

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验